BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maimaiti A, Jiang L, Wang X, Shi X, Pei Y, Hao Y, Paerhati H, Zibibula Y, Abudujielili A, Kasimu M. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA. Clin Neurol Neurosurg 2021;201:106464. [PMID: 33454543 DOI: 10.1016/j.clineuro.2020.106464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Liang Y, Gareev I, Liang Y, Liu R, Wang N, Yang G. LncRNA as potential biomarker and therapeutic target in glioma. Mol Biol Rep 2023;50:841-51. [PMID: 36331751 DOI: 10.1007/s11033-022-08056-y] [Reference Citation Analysis]
2 Kazemifad N, Kazemi M, Shahrokh S, Aghdaei HA. NF-κB pathway related long non-coding RNAs in inflammatory bowel disease.. [DOI: 10.21203/rs.3.rs-2293193/v1] [Reference Citation Analysis]
3 Gao C, Zhou G, Cheng M, Feng L, Cao P, Zhou G. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Front Genet 2022;13:956094. [DOI: 10.3389/fgene.2022.956094] [Reference Citation Analysis]
4 Wang HQ, Qian CH, Guo ZY, Li PM, Qiu ZJ. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression via targeting miR-299-3p. World J Gastroenterol 2022; 28(35): 5141-5153 [DOI: 10.3748/wjg.v28.i35.5141] [Reference Citation Analysis]
5 Wu X, Yang L, Wang J, Hao Y, Wang C, Lu Z. The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy. Front Immunol 2022;13:897754. [PMID: 35619711 DOI: 10.3389/fimmu.2022.897754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yin L, Zhou L, Gao S, Feng Y, Zhu H, Xiang J, Xu R. Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling. Front Mol Biosci 2022;9:807418. [DOI: 10.3389/fmolb.2022.807418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Han T, Zuo Z, Qu M, Zhou Y, Li Q, Wang H. Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma. Front Pharmacol 2021;12:748993. [PMID: 34712139 DOI: 10.3389/fphar.2021.748993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Chen ZA, Tian H, Yao DM, Zhang Y, Feng ZJ, Yang CJ. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Front Oncol 2021;11:738477. [PMID: 34568075 DOI: 10.3389/fonc.2021.738477] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
9 Brlek P, Kafka A, Bukovac A, Pećina-Šlaus N. Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain. Cancers (Basel) 2021;13:3247. [PMID: 34209611 DOI: 10.3390/cancers13133247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Chen Y, Shen L, Chen B, Han X, Yu Y, Yuan X, Zhong L. The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer. Ann Transl Med 2021;9:843. [PMID: 34164477 DOI: 10.21037/atm-21-1392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]